Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Long-term results after the glycoprotein iib/iiia inhibitor abciximab in unstable angina - one-year survival in the gusto iv-acs (global use of strategies to open occluded coronary arteries iv - acute coronary syndrome) trial

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Ottervanger, J. P.
  • Armstrong, P.
  • Barnathan, E. S.
  • Boersma, E.
  • Cooper, J. S.
  • Ohman, E. M.
  • James, S.
  • Topol, Eric
  • Wallentin, L.
  • Simoons, M. L.
  • Invest, Gusto Iv-Acs

publication date

  • January 2003

journal

  • Circulation  Journal

subject areas

  • Acute Disease
  • Adult
  • Aged
  • Angina, Unstable
  • Antibodies, Monoclonal
  • C-Reactive Protein
  • Coronary Disease
  • Follow-Up Studies
  • Humans
  • Immunoglobulin Fab Fragments
  • Middle Aged
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Risk Factors
  • Survival Analysis
  • Syndrome
  • Treatment Outcome
  • Troponin
scroll to property group menus

Research

keywords

  • acute coronary syndromes
  • coronary disease
  • prognosis
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0009-7322

Digital Object Identifier (DOI)

  • 10.1161/01.cir0000046487.06811.5e

PubMed ID

  • 12551868
scroll to property group menus

Additional Document Info

start page

  • 437

end page

  • 442

volume

  • 107

issue

  • 3

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support